Revisiting the Paradox of Interferon‐Stimulated Gene Expression as a Predictor of Hepatitis C Virus Treatment Response, a Decade Later
Open Access
- 28 July 2018
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 68 (6) , 2053-2055
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct‐Acting Antiviral TherapyHepatology, 2018
- Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatmentHepatology Communications, 2018
- Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapyPLOS ONE, 2017
- IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infectionScientific Reports, 2017
- Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcomeJournal of Clinical Investigation, 2014
- Emerging concepts in immunity to hepatitis C virus infectionJournal of Clinical Investigation, 2013
- Regulation of hepatic innate immunity by hepatitis C virusNature Medicine, 2013
- HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III InterferonsGastroenterology, 2012
- Cell-Type Specific Gene Expression Signature in Liver Underlies Response to Interferon Therapy in Chronic Hepatitis C InfectionGastroenterology, 2010
- Interferon signaling and treatment outcome in chronic hepatitis CProceedings of the National Academy of Sciences, 2008